BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29683859)

  • 1. Correlation with lymphocyte infiltration, but lack of prognostic significance of MECA-79-positive high endothelial venules in primary malignant melanoma.
    Sebestyén T; Mohos A; Liszkay G; Somlai B; Gaudi I; Ladányi A
    Melanoma Res; 2018 Aug; 28(4):304-310. PubMed ID: 29683859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma.
    Avram G; Sánchez-Sendra B; Martín JM; Terrádez L; Ramos D; Monteagudo C
    Histopathology; 2013 Dec; 63(6):852-61. PubMed ID: 24102908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
    Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
    Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes.
    Martinet L; Le Guellec S; Filleron T; Lamant L; Meyer N; Rochaix P; Garrido I; Girard JP
    Oncoimmunology; 2012 Sep; 1(6):829-839. PubMed ID: 23162750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Density of high endothelial venules and PDL-1 expression: relationship with tumor-infiltrating lymphocytes in primary cutaneous melanomas.
    Stolfo JB; Motta ACD
    An Acad Bras Cienc; 2024; 96(1):e20230441. PubMed ID: 38511744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of B-cell density in cutaneous melanoma.
    Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
    Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
    Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
    Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.
    Martinet L; Filleron T; Le Guellec S; Rochaix P; Garrido I; Girard JP
    J Immunol; 2013 Aug; 191(4):2001-8. PubMed ID: 23825314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High endothelial venules (HEVs) in immunity, inflammation and cancer.
    Blanchard L; Girard JP
    Angiogenesis; 2021 Nov; 24(4):719-753. PubMed ID: 33956259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High endothelial venule-like vessels and lymphocyte recruitment in testicular seminoma.
    Sakai Y; Hoshino H; Kitazawa R; Kobayashi M
    Andrology; 2014 Mar; 2(2):282-9. PubMed ID: 24519996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma.
    Ladányi A; Somlai B; Gilde K; Fejös Z; Gaudi I; Tímár J
    Clin Cancer Res; 2004 Jan; 10(2):521-30. PubMed ID: 14760073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of tumor-infiltrating immune cells in melanoma].
    Ladányi A
    Magy Onkol; 2013 Jun; 57(2):85-95. PubMed ID: 23795353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma.
    Kiss J; Tímár J; Somlai B; Gilde K; Fejôs Z; Gaudi I; Ladányi A
    Pathol Oncol Res; 2007; 13(1):21-31. PubMed ID: 17387385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma.
    Lynch KT; Young SJ; Meneveau MO; Wages NA; Engelhard VH; Slingluff CL; Mauldin IS
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34103353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
    Chen H; Li G; Cui Y; Zhang Q; Li B; Liu X
    Cancer Med; 2023 Mar; 12(5):5450-5460. PubMed ID: 36259639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
    Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
    Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.
    Martinet L; Garrido I; Filleron T; Le Guellec S; Bellard E; Fournie JJ; Rochaix P; Girard JP
    Cancer Res; 2011 Sep; 71(17):5678-87. PubMed ID: 21846823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High endothelial venules are present in pharyngeal and laryngeal carcinomas and they are associated with better prognosis.
    Karpathiou G; Dumollard JM; Gavid M; Casteillo F; Vieville M; Prades JM; Froudarakis M; Peoc'h M
    Pathol Res Pract; 2021 Apr; 220():153392. PubMed ID: 33647862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
    Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
    JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.